WO2013123487A1 - Alkalized acacia gum adhesive for oral adhering discs - Google Patents

Alkalized acacia gum adhesive for oral adhering discs Download PDF

Info

Publication number
WO2013123487A1
WO2013123487A1 PCT/US2013/026609 US2013026609W WO2013123487A1 WO 2013123487 A1 WO2013123487 A1 WO 2013123487A1 US 2013026609 W US2013026609 W US 2013026609W WO 2013123487 A1 WO2013123487 A1 WO 2013123487A1
Authority
WO
WIPO (PCT)
Prior art keywords
troche
layer
alkalizer
adhering
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2013/026609
Other languages
English (en)
French (fr)
Inventor
Jeffrey T. Haley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orahealth LLC
Original Assignee
Orahealth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN201380010108.2A priority Critical patent/CN104136010A/zh
Priority to EP20153705.7A priority patent/EP3673902B1/en
Priority to HK14112389.8A priority patent/HK1198915A1/xx
Priority to RU2014136413A priority patent/RU2631485C2/ru
Priority to KR1020147022417A priority patent/KR20140124375A/ko
Priority to EP13749952.1A priority patent/EP2814467B1/en
Application filed by Orahealth LLC filed Critical Orahealth LLC
Priority to US14/379,692 priority patent/US9789061B2/en
Priority to JP2014557863A priority patent/JP6153949B2/ja
Publication of WO2013123487A1 publication Critical patent/WO2013123487A1/en
Priority to IN6135DEN2014 priority patent/IN2014DN06135A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Definitions

  • Oral adhering discs also called adhering troches, are known for time release of ingredients into saliva in the mouth or into the mucosa to which the disc is adhered or into mucosa that the disc touches while the disc is adhered to teeth or gums.
  • Some oral adhering discs have two layers, a thin adhesive layer and a thicker, slowly dissolving ingredient release layer.
  • Many synthetic hydrophilic compounds are known for use as the adhesive layer, such as poly-acrylic acid, carbomer, carbopol, and povidone.
  • An effective natural compound, in sufficient concentration, is acacia gum, also known as gum arabic. As it dissolves in saliva, acacia gum adhesive is acidic, producing a local pH below 5.5, which is more acidic than desirable for contact with teeth.
  • adhering objects need not be disc shaped. They may be squarish or oval or oblong or any other shape that is roughly flat at least on one side.
  • a generic term that includes all such shapes is "adhering troche" (which a term for an object held in the mouth to achieve an effect).
  • the present invention provides a natural muco-adhesive composition that is effective for adhering troches and is less acidic than pure acacia gum made by mixing an alkalizer (base) with the acacia gum.
  • the invention is an adhering troche having two sides that, when held in a human mouth, adheres and remains in the mouth as a single item that does not smear or break apart, made by a process comprising, (a) forming a first layer, roughly disc-shaped and having a roughly flat side at least 5 mm in two dimensions, comprising an ingredient to be released into saliva and/or mucosa; (b) forming a second, adhesive layer, roughly disc-shaped and having a roughly flat side at least 5 mm in two dimensions, comprising at least 80% acacia gum mixed with a sufficient quantity of alkalizer that the pH of the mixture is 5.5 or higher when dissolved in 10 parts water; and (c) adhering the layers to each other, side to side, such that one entire side of the resulting troche is adhesive and the other entire side of the resulting troche is not adhesive.
  • the particles of the alkalizer may be adhered to particles of the acacia gum by a wet granulation process and the resulting combined particles may then be pressed into a bi-layer troche with a bi-layer tablet press.
  • the particles of the alkalizer may be dry mixed with particles of the acacia gum and the resulting mixture then pressed into a bi-layer troche with a bi-layer tablet press.
  • the particles of the alkalizer may be wet mixed with particles of the acacia gum and the resulting mixture then dried into granules and the granules then pressed into a bi-layer troche with a bi-layer tablet press.
  • the particles of the alkalizer may be wet mixed with particles of the acacia gum and the resulting mixture then spread into a layer on a sheet and the sheet then cut into a bi-layer troche.
  • the particles of the alkalizer may be mixed with particles of the acacia gum and the resulting mixture then pressure extruded to make a bi-layer sheet which may be cut into troches. These adhering troches may be made by hot pressing the sheet with dies that hot-squish the sheet to separate it into individual troches and then cooling.
  • the adhesive layer adheres to a roof of a mouth of a human strongly enough to hold triple the weight of the troche against force of gravity and strongly enough to hold the weight of the troche plus an additional 680 milligrams against force of gravity.
  • the preferred alkalizer is calcium carbonate.
  • the invention is an adhering troche having two sides that, when held in a human mouth, adheres and remains in the mouth as a single item that does not smear or break apart, comprising (a) a first layer, roughly disc-shaped and having a roughly flat side at least 5 mm in two dimensions, comprising an ingredient to be released into saliva or mucosa; (b) a second, adhesive layer, roughly disc-shaped and having a roughly flat side at least 5 mm in two dimensions, comprising at least 80% acacia gum mixed with a sufficient quantity of alkalizer that the pH of the mixture is 5.5 or higher when dissolved in 10 parts water; and (c) the layers being adhered to each other, side to side, such that one entire side of the resulting troche is adhesive and the other entire side of the resulting troche is not adhesive.
  • the invention is an adhering troche, at least 5 mm in two dimensions, that, when held in a human mouth, adheres and remains in the mouth as a single item that does not smear or break apart, comprising, (a) a first layer comprising an ingredient to be released into saliva; and (b) a second, adhesive layer comprising at least 80% acacia gum mixed with a sufficient quantity of alkalizer that the pH of the mixture 5.5 or higher dissolved in 10 parts water.
  • Figure 1 presents a table of experimental embodiments of the invention made with mixtures of acacia gum with calcium carbonate.
  • the acacia gum is pressed from a dry powder into one layer of a bi- layer disc with a bi-layer tablet press as taught by US patent application # 11/800381 filed May 4, 2007 by the same inventor which is incorporated by reference.
  • the alkalizer (base) may be mixed as a dry powder with the acacia gum powder, or it may be granulated with the acacia gum powder in a wet-granulation process or a dry granulation process.
  • the acacia gum may be mixed with a liquid such as water or alcohol to form a thick paste which is then spread onto a sheet, such as a sheet of a composition including an ingredient to be delivered.
  • a sheet such as a sheet of a composition including an ingredient to be delivered.
  • the sheet may be dried and then cut into discs or first cut into discs and then dried.
  • the alkalizer is mixed into the paste before spreading on the sheet.
  • the acacia gum may be mixed with the alkalizer and then pressure extruded to form a sheet from which discs are cut.
  • the alkalizer (base) is added in the least amount that achieves the desired neutralization, to keep the acacia gum as concentrated as possible to maintain maximum adhesive effectiveness.
  • the adhesive layer should adhere to a roof of a mouth of a human strongly enough to hold triple the weight of the disc against force of gravity.
  • the adhesive layer should adhere to a roof of a mouth of a human strongly enough to hold the weight of the disc plus an additional 680 milligrams against force of gravity.
  • the acacia gum for adequate adhesive strength, should be at least 80%, allowing up to 20% alkalizer or other additives.
  • Any known alkalizer that allows the finished product to remain adequately shelf stable may be used.
  • the alkalizer may be mixed with wet acacia gum, neutralizing the acacia gum before it is granulated, dried, and tablet pressed or spread as a paste.
  • a strong alkalizer such as KOH (potassium hydroxide) or sodium hydroxide, may be used and titrated to a pH between 5.5 and 8.0, preferably 6.0 - 7.0.
  • acacia gum For ease of manufacturing finished discs with a bi-layer tablet press, it is preferred to obtain the acacia gum as a powder, then mix in a powdered alkalizer, and then use the mixture directly in a tablet press.
  • Any alkalizer that can be obtained as a powder and will remain shelf stable when mixed with powdered acacia gum can be used. Examples include calcium carbonate, magnesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium carbonate, magnesium hydroxide, aluminum hydroxide, and C 7 H 5 Bi0 4 . Effective ratios of calcium carbonate to acacia gum range down to 1:50.
  • a preferred formulation uses fine powder calcium carbonate in a ratio with acacia gum calcium within the range 1 : 15 to 1 : 50.
  • the presently most preferred ratio is 1 to 40. Tests show that this mixture keeps the pH above 5.5 as the mixture dissolves in distilled water. Measured pH's range from 6.0 to 6.4. If the amount of calcium carbonate is increased, the pH can be as high as 7.0 but this is not optimal as the adhesiveness of the acacia gum is somewhat reduced.
  • the powders may be pressed into a disc shaped tablet.
  • a disc shaped tablet is preferably 9-16 mm in diameter and 70-800 milligrams in weight.
  • the upper punch should be shaped for good contact with a surface in the mouth, usually essentially flat, sometimes with a bump in the center to create a dimple in the disc surface, sometimes cupped to give a domed surface such as for adhesion to the roof of the mouth.
  • the lower punch may be cupped to provide a domed outer surface on a thick disc, or it may be nearly flat for a thin disc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
PCT/US2013/026609 2012-02-19 2013-02-18 Alkalized acacia gum adhesive for oral adhering discs Ceased WO2013123487A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP20153705.7A EP3673902B1 (en) 2012-02-19 2013-02-18 Alkalized acacia gum adhesive for oral adhering discs
HK14112389.8A HK1198915A1 (en) 2012-02-19 2013-02-18 Alkalized acacia gum adhesive for oral adhering discs
RU2014136413A RU2631485C2 (ru) 2012-02-19 2013-02-18 Клейкое вещество на основе гуммиарабика, смешанное с карбонатом кальция, для пероральных прилипающих дисков
KR1020147022417A KR20140124375A (ko) 2012-02-19 2013-02-18 구강 접착 정제용 알칼리성 아카시아 검
EP13749952.1A EP2814467B1 (en) 2012-02-19 2013-02-18 Alkalized acacia gum adhesive for oral adhering discs
CN201380010108.2A CN104136010A (zh) 2012-02-19 2013-02-18 用于口腔粘附圆片的碱化金合欢树胶粘合剂
US14/379,692 US9789061B2 (en) 2012-02-19 2013-02-18 Acacia gum adhesive with calcium carbonate for oral adhering discs
JP2014557863A JP6153949B2 (ja) 2012-02-19 2013-02-18 口内接着ディスクのための炭酸カルシウムが混合されたアラビアゴムの接着剤
IN6135DEN2014 IN2014DN06135A (enExample) 2012-02-19 2014-07-21

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600659P 2012-02-19 2012-02-19
US61/600,659 2012-02-19

Publications (1)

Publication Number Publication Date
WO2013123487A1 true WO2013123487A1 (en) 2013-08-22

Family

ID=48984813

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/026609 Ceased WO2013123487A1 (en) 2012-02-19 2013-02-18 Alkalized acacia gum adhesive for oral adhering discs

Country Status (9)

Country Link
US (1) US9789061B2 (enExample)
EP (2) EP3673902B1 (enExample)
JP (1) JP6153949B2 (enExample)
KR (1) KR20140124375A (enExample)
CN (2) CN108904460A (enExample)
HK (1) HK1198915A1 (enExample)
IN (1) IN2014DN06135A (enExample)
RU (1) RU2631485C2 (enExample)
WO (1) WO2013123487A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015056196A1 (en) * 2013-10-16 2015-04-23 Orahealth Corporation Treating mucosal lesions with hyaluronan delivered from an adhering troche
WO2018193351A1 (en) * 2017-04-16 2018-10-25 Orahealth Corp. Gelatin and compression binder for use in oral adhering discs

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11612564B2 (en) 2018-04-21 2023-03-28 Quest Products, Llc Bilayer adhering lozenge effective to mask undesirable flavor
US12233158B2 (en) 2021-06-04 2025-02-25 Quest Products, Llc Orally adhering lozenges containing soluble dietary fiber
US12485089B1 (en) 2025-03-13 2025-12-02 Quest Products, Llc Adhering lozenge with high amount of sparsely soluble active ingredient

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2234337C2 (ru) * 1997-09-26 2004-08-20 Ноувен Фамэсьютикэлз, Инк. Биоадгезивная композиция (варианты), способ ее получения (варианты), устройство для доставки через слизистую оболочку активного агента, способ пролонгированного местного введения одного или более активных агентов субъекту (варианты) и способ сокращения времени, требуемого для приклеивания композиции к слизистой ткани
US20070081949A1 (en) * 2003-09-05 2007-04-12 Arrow No. 7 Limited Buccal drug delivery
WO2007120768A1 (en) * 2006-04-13 2007-10-25 Haley Jeffrey T Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures
US20070274927A1 (en) * 2006-05-23 2007-11-29 Jeffrey T. Haley Adherent polyol troche
WO2009036084A2 (en) 2007-09-11 2009-03-19 Orahealth Corporation Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach
WO2009043588A2 (en) * 2007-10-02 2009-04-09 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Ph regulating antibacterial films for the oral or vaginal cavity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152451A (ja) * 1982-03-01 1983-09-10 ナビスコ・ブランズ・インコ−ポレ−テツド チユ−インガムおよび舐剤に無糖皮を被覆する改良法
US4828845A (en) * 1986-12-16 1989-05-09 Warner-Lambert Company Xylitol coated comestible and method of preparation
US5302628A (en) * 1992-02-03 1994-04-12 Block Drug Company, Inc. Denture adhesive composition
JPH08301742A (ja) * 1995-04-28 1996-11-19 Ezaki Glico Co Ltd だ液のpH低下を防止する口腔用組成物
JP3138234B2 (ja) * 1997-06-17 2001-02-26 十勝農業協同組合連合会 有用微生物コーティング種子
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
EP2338475A3 (en) * 2001-11-05 2012-08-08 Orahealth Corporation Treating canker sores with patches to speed healing and relieve pain
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
CN101484146A (zh) * 2006-05-23 2009-07-15 奥拉黑尔斯公司 木糖醇锭剂及其用法
EP2918276A1 (en) * 2006-05-30 2015-09-16 Orahealth Corporation Cobalamin compositions and methods for treating or preventing mucositis
CN100544722C (zh) * 2006-10-12 2009-09-30 朱志宏 一种口腔内使用的左羟丙哌嗪药物组合物
EP1980245A1 (en) * 2007-04-11 2008-10-15 Cephalon France Bilayer lyophilized pharmaceutical compositions and methods of making and using same
WO2011126537A2 (en) * 2010-04-05 2011-10-13 Orahealth Corporation Oral adhering compositions that apply rhizophora mangle extract in the mouth

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2234337C2 (ru) * 1997-09-26 2004-08-20 Ноувен Фамэсьютикэлз, Инк. Биоадгезивная композиция (варианты), способ ее получения (варианты), устройство для доставки через слизистую оболочку активного агента, способ пролонгированного местного введения одного или более активных агентов субъекту (варианты) и способ сокращения времени, требуемого для приклеивания композиции к слизистой ткани
US20070081949A1 (en) * 2003-09-05 2007-04-12 Arrow No. 7 Limited Buccal drug delivery
WO2007120768A1 (en) * 2006-04-13 2007-10-25 Haley Jeffrey T Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures
US20070274927A1 (en) * 2006-05-23 2007-11-29 Jeffrey T. Haley Adherent polyol troche
WO2009036084A2 (en) 2007-09-11 2009-03-19 Orahealth Corporation Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach
WO2009043588A2 (en) * 2007-10-02 2009-04-09 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Ph regulating antibacterial films for the oral or vaginal cavity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015056196A1 (en) * 2013-10-16 2015-04-23 Orahealth Corporation Treating mucosal lesions with hyaluronan delivered from an adhering troche
US9688779B2 (en) 2013-10-16 2017-06-27 Orahealth Corp. Treating mucosal lesions with hyaluronan delivered from an adhering troche
US10479842B2 (en) 2013-10-16 2019-11-19 Quest Products, Llc Treating mucosal lesions with hyaluronan delivered from an adhering troche
WO2018193351A1 (en) * 2017-04-16 2018-10-25 Orahealth Corp. Gelatin and compression binder for use in oral adhering discs

Also Published As

Publication number Publication date
JP6153949B2 (ja) 2017-06-28
EP3673902B1 (en) 2022-01-05
EP2814467A4 (en) 2015-08-26
EP2814467A1 (en) 2014-12-24
EP2814467B1 (en) 2020-03-11
EP3673902A1 (en) 2020-07-01
US9789061B2 (en) 2017-10-17
KR20140124375A (ko) 2014-10-24
IN2014DN06135A (enExample) 2015-08-14
RU2631485C2 (ru) 2017-09-22
JP2015507021A (ja) 2015-03-05
RU2014136413A (ru) 2016-03-27
CN104136010A (zh) 2014-11-05
US20150272871A1 (en) 2015-10-01
CN108904460A (zh) 2018-11-30
HK1198915A1 (en) 2015-06-19

Similar Documents

Publication Publication Date Title
US9789061B2 (en) Acacia gum adhesive with calcium carbonate for oral adhering discs
JP5154924B2 (ja) ジェランガムを含む膨張可能な投与形態
AU2006212021B2 (en) Pharmaceutical compositions useful in the transmucosal administration of drugs
Patel et al. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride
JP5508612B1 (ja) 歯牙用貼付シート
TW200906317A (en) Embedded liquid lubricants for tableting
KR101788350B1 (ko) 아카보스를 함유하는 경구 붕해 정제
TWI759273B (zh) 牙齒或牙齒周邊部貼附用製劑
US20180296466A1 (en) Gelatin and compression binder for use in oral adhering discs
JP6320297B2 (ja) 発泡性口腔用組成物、発泡性口腔用固形製剤及び発泡性口腔用製品
JP2009073778A (ja) グルクロノラクトン含有固形製剤
JP2015507021A5 (enExample)
CN105012955B (zh) 一种用于直接压片制备口崩片的预混辅料
MX2007011976A (es) Composiciones farmaceuticas novedosas utiles en el tratamiento de la enfermedad de parkinson.
CN1615857A (zh) 氨来呫诺双层口腔粘附片及其制备方法
Moreton Magnesium Stearate–Its Importance and Potential Impact on Dissolution of Oral Solid Dosage Forms
JP2011136939A (ja) 生薬含有錠剤、生薬含有錠剤用の生薬担持粒子の製造方法
JPWO2017002799A1 (ja) 易服用性固形製剤(有核錠剤)の製造方法及び易服用性固形製剤
JP3292003B2 (ja) 水性粘着剤組成物
JPS6222713A (ja) 粘膜付着製剤
JP3637968B1 (ja) 胃内崩壊性錠剤
HUP1100272A2 (en) Pharmaceutical use of silicic acid
JP2019182818A (ja) 舌苔除去用の口腔内崩壊錠及び舌苔除去方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13749952

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20147022417

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2014557863

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 14379692

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2014136413

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 2013749952

Country of ref document: EP